Adria Arjona, Eva De Dominici, Sydney Chandler and Grace Van Patten are finalists to play Maxima in James Gunn's "Superman" ...

LinkedIn is facing two lawsuits over its practice of scanning users’ browsers to determine which extensions they’re running.

Jeremiah Fears set a Pelicans rookie record for points in a game with 40, and the New Orleans Pelicans snapped an eight-game losing streak with a 156-137 victory over the Utah Jazz, who lost their ...

LinkedIn runs a hidden JavaScript script called Spectroscopy that silently probes over 6,000 Chrome extensions and collects ...

After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...